Travere Therapeutics (TVTX) Stock Price & Financial Analysis
Travere Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Travere Therapeutics
What is the current stock price for TVTX?
As of the latest trading session, TVTX stock trades at $55.15. The 52-week range is $13.97–$55.99, with a day range of $53.75–$55.99.
What is the P/E ratio for TVTX?
The P/E ratio (Price-to-Earnings) for TVTX is shown in the Key Statistics section. This valuation metric helps compare Travere Therapeutics, Inc. to industry peers.
Does TVTX pay dividends?
Travere Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for TVTX?
Based on 12 analysts, the consensus for TVTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of TVTX?
Travere Therapeutics's market capitalization is $5.07B, classifying it as a mid-cap company. Travere Therapeutics operates in the Healthcare sector within the Biotechnology industry.